KAREN A DAWES
CIK 1261506 · Chairperson of the Board · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.11M
Companies
5
Total Filings
81
Lifetime Open-Market Net
-$18.21M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGEN | Director | 92,816 | $130.59 | $12.12M | -$18.17M | 51 | 2026-05-18 |
| Barinthus Biotherapeutics plc. (VACC) Delisted | Director | 1,700 | $5.00 | $8.5K | $28.9K | 5 | 2025-06-11 |
| ASRT | Director | 84,589 | $23.48 | $1.99M | -$93.0K | 4 | 2020-05-11 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | 12,867 | — | — | $27.3K | 17 | 2018-05-10 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Chairperson of the Board | 2,250 | — | — | $0 | 4 | 2008-04-30 |
Recent Filings · Page 5 of 9
81 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-17 | RGEN | Grant (A) | +2,080 | $0 | EDGAR |
| 2018-05-15 | RGEN | Mixed | — | -$734.3K | EDGAR |
| 2018-05-10 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-16 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-22 | RGEN | Grant (A) | +1,714 | $0 | EDGAR |
| 2017-03-22 | RGEN | Mixed | +17,479 | -$217 | EDGAR |
| 2016-07-15 | RGEN | Grant (A) | +20,000 | $0 | EDGAR |
| 2016-06-28 | RGEN | Mixed | +13,018 | $2 | EDGAR |
| 2016-05-20 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-13 | RGEN | Grant (A) | +2,505 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.